Form 4: Semler Scientific CFO, Renae Cormier, Reports Stock Option Grant
SEC Filing
Renae Cormier, CFO of Semler Scientific, Inc., reports the acquisition of stock options.
Summary
- Renae Cormier, the Chief Financial Officer of Semler Scientific, Inc. (SMLR), filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on May 2, 2025.
- Cormier acquired 20,000 stock options with an exercise price of $36.16.
- These options vest over four years, with 1/4 vesting on the first anniversary of the grant date and the remaining 3/4 vesting monthly thereafter.
- The options expire on May 2, 2035.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment, simply reporting a transaction.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that the CFO has been granted stock options, which is a common form of executive compensation.
Stakeholder Impact
- The grant of stock options aligns the CFO's interests with those of the shareholders, incentivizing her to increase the company's value.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of stock option grant. |
| 05/02/2026 | First vesting date for the stock options (1/4th of the shares). |
| 05/02/2035 | Expiration date of the stock options. |
| 05/05/2025 | Date of Form 4 filing. |
Keywords
Form 4, Semler Scientific, Stock Options, Renae Cormier, CFO, SMLR, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.